| Briana Victoria Hodge, PA-C | |
|
501 Kenmore Ave, Buffalo, NY 14223-2864 | |
| (716) 768-4636 | |
| Not Available |
| Full Name | Briana Victoria Hodge |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 501 Kenmore Ave, Buffalo, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174384697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 031237-01 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Briana Victoria Hodge, PA-C 501 Kenmore Ave, Buffalo, NY 14223-2864 Ph: (716) 768-4636 | Briana Victoria Hodge, PA-C 501 Kenmore Ave, Buffalo, NY 14223-2864 Ph: (716) 768-4636 |
News Archive
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
Bruker is launching InsightMR software for on-line NMR analysis of chemical processes at Pittcon 2015. For the first time, a software platform enables the adjustment of experimental parameters based on real time data during the analysis of chemical processes by NMR spectroscopy.
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells - outlining how cancer cells hijack specific pathways for uncontrolled proliferation - will lead to more efficient ways to fight it.
In this prospective cohort study, presented today at the ESC Congress 2011, discontinuation of smokeless tobacco after a myocardial infarction (MI) is associated with a lower risk of subsequent mortality. Investigators found that post MI snus quitters had a 44 % lower risk of total mortality.
Innovation at the University of Louisville involving multiple departments at the university has led to a promising solution for the shortage of swabs in COVID-19 test kits.
› Verified 4 days ago
Musa Saeed, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1374 | |
Dr. Reena Bose, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 899 Main St, Buffalo, NY 14203 Phone: 716-878-2700 Fax: 716-878-2701 | |
Michael S Winnicki, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-4693 | |
John Crane, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-829-2676 | |
Samjot S Dhillon, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1110 | |
Bonnie Theresa Gleason, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 565 Abbott Rd, Buffalo, NY 14220 Phone: 716-560-8416 | |
Sanjivini Wadhwa, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-4119 |